Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
X-14450--phenylalanylleucine measurement	EFO_0021369	[Quantification of the amount of X-14450--phenylalanylleucine in a sample.]
Torsion dystonia	HP_0001304	[Sustained involuntary muscle contractions that produce twisting and repetitive movements of the body.]
X-14374 measurement	EFO_0021368	[Quantification of the amount of X-14374 in a sample.]
X-14086 measurement	EFO_0021363	[Quantification of the amount of X-14086 in a sample.]
obsolete_partial duplication of the long arm of chromosome 3	Orphanet_262851
X-14057 measurement	EFO_0021362	[Quantification of the amount of X-14057 in a sample.]
X-14205--alpha-glutamyltyrosine measurement	EFO_0021365	[Quantification of the amount of X-14205--alpha-glutamyltyrosine in a sample.]
Parkinsonism	HP_0001300	[Characteristic neurologic anomaly resulting from degeneration of dopamine-generating cells in the substantia nigra, a region of the midbrain, characterized clinically by shaking, rigidity, slowness of movement and difficulty with walking and gait.]
inherited susceptibility to asthma	MONDO_0010940
X-14189--leucylalanine measurement	EFO_0021364	[Quantification of the amount of X-14189--leucylalanine in a sample.]
triiodothyronine measurement	EFO_0008392	[Quantification of the thyroid hormone triiodothyronine (T3) typically in the blood, usually as an indicator of thyroid function]
reaction time measurement	EFO_0008393	[In psychology, the quantification of the interval of time between the presentation of a stimulus to a subject and the beginning of the subject's response to that stimulus. Several categories of reaction time, such as simple reaction time and choice reaction time, have been established and studied in experimental psychology to assess general alertness and motor speed.]
X-14056 measurement	EFO_0021361	[Quantification of the amount of X-14056 in a sample.]
verbal-numerical reasoning measurement	EFO_0008394	[Quantification of verbal and/or numerical reasoning, typically based on a written or multiple choice test]
response to darapladib	EFO_0008395	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of darapladib stimulus. Darapladib is a lipoprotein-associated phospholipase A2 inhibitor, developed for the treatment of cardiovascular disease.]
X-13859 measurement	EFO_0021360	[Quantification of the amount of X-13859 in a sample.]
prothrombin time measurement	EFO_0008390	[Quantification of the clotting tendency of blood plasma following the addition of tissue factor. Prothrombin time requires the presence of factors I, II, V, VII, and X. It measures the extrinsic pathway of coagulation and can be used in conjunction with the activated partial thromboplastin time (aPTT) which measures the intrinsic pathway. It is used as a screening test and can be affected by vitamin K deficiency, liver disease, warfarin therapy or intestinal problems.]
erythropoetin measurement	EFO_0008391	[Quantification of the glycoprotein erythropoetin typically in the blood]
low phospholipid associated cholelithiasis	MONDO_0010939	[Low phospholipid associated cholelithiasis is a rare genetic hepatic disease characterized by cholesterol gallstones and intrahepatic stones developing before the age of 40 years.]
peroxisome biogenesis disorder type 3B	MONDO_0009959	[A genetic disorder characterized by abnormalities in the breakdown of phytanic acid. It results in accumulation of phytanic acid in the blood, brain and other tissues. Signs and symptoms include retinitis pigmentosa which may lead to blindness, hearing problems and deafness, hypotonia, ataxia, nystagmus, facial deformities, and mental and growth retardation.]